1,911 results on '"Toyooka, Shinichi"'
Search Results
52. Early-stage antibody kinetics after the third dose of BNT162b2 mRNA COVID-19 vaccination measured by a point-of-care fingertip whole blood testing
53. Survival and prognostic factors in patients undergoing pulmonary metastasectomy for lung metastases from retroperitoneal sarcoma
54. Identification of targetable kinases in idiopathic pulmonary fibrosis
55. One-step nucleic acid amplification for intraoperative diagnosis of lymph node metastasis in lung cancer patients: a single-center prospective study
56. Increased Oxidative Stress and Decreased Citrulline in Blood Associated with Severe Novel Coronavirus Pneumonia in Adult Patients.
57. Utility of neutrophil-to-lymphocyte ratio as an indicator of tumor immune status in non-small cell lung cancer.
58. Treatment patterns and clinical outcomes of resectable clinical stage III non‐small cell lung cancer in a Japanese real‐world setting: Surgery cohort analysis of the SOLUTION study.
59. Predictive Value of PERCIST for Locally Advanced Non-Small Cell Lung Cancer Treated with Preoperative Induction Therapy – A Multicenter Study in Japan.
60. Adrenergic microenvironment driven by cancer‐associated Schwann cells contributes to chemoresistance in patients with lung cancer.
61. Current status of inhaled nitric oxide therapy for lung transplantation in Japan: a nationwide survey
62. The prognostic nutritional index is correlated negatively with the lung allocation score and predicts survival after both cadaveric and living-donor lobar lung transplantation
63. Lysyl oxidase-like 4 promotes the invasiveness of triple-negative breast cancer cells by orchestrating the invasive machinery formed by annexin A2 and S100A11 on the cell surface
64. Plasma concentrations of histidine-rich glycoprotein in primary graft dysfunction after lung transplantation
65. Effects of case volume on short- and long-term outcomes following cadaveric lung transplantation in Japan
66. Chronic Lung Injury After Trimodality Therapy for Locally Advanced Non-Small Cell Lung Cancer
67. “Hybrid Lung Transplantation” Combining Living Donor and Cadaveric Lung Transplants: Report of 2 Cases
68. Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Locally Advanced Non-small-cell Lung Cancer Treated with Trimodality Therapy
69. Sarcopenia is related to poor prognosis in patients after trimodality therapy for locally advanced non-small cell lung cancer
70. The prognostic impact of sarcopenia on elderly patients undergoing pulmonary resection for non-small cell lung cancer
71. A Simple Prognostic Benefit Scoring System for Sarcoma Patients with Pulmonary Metastases: Sarcoma Lung Metastasis Score
72. Suv4-20h2 protects against influenza virus infection by suppression of chromatin loop formation
73. Allele-Specific Role of ERBB2 in the Oncogenic Function of EGFR L861Q in EGFR-Mutant Lung Cancers
74. Effectiveness of scheduled intravenous acetaminophen in the postoperative pain management of video-assisted thoracic surgery
75. Long-term clinical follow-up after lung transplantation in patient with scoliosis: a case report
76. SRC Family Kinase Inhibition Targets YES1 and YAP1 as Primary Drivers of Lung Cancer and as Mediators of Acquired Resistance to ALK and Epidermal Growth Factor Receptor Inhibitors
77. Continuing surgical education of non-technical skills
78. Lung transplantation for Kartagener syndrome: technical aspects and morphological adaptation of the transplanted lungs
79. Effect of isoflavones on breast cancer cell development and their impact on breast cancer treatments
80. The neutrophil-to-lymphocyte ratio as a novel independent prognostic factor for multiple metastatic lung tumors from various sarcomas
81. The heterodimer S100A8/A9 is a potent therapeutic target for idiopathic pulmonary fibrosis
82. PAI-1 mediates acquired resistance to MET-targeted therapy in non-small cell lung cancer.
83. Survival Outcomes of Treatment with Radiofrequency Ablation, Stereotactic Body Radiotherapy, or Sublobar Resection for Patients with Clinical Stage I Non–Small-Cell Lung Cancer: A Single-Center Evaluation
84. Evaluation of Therapeutic Target Gene Expression Based on Residual Cancer Burden Classification After Neoadjuvant Chemotherapy for HER2-Negative Breast Cancer
85. Correction to: Periostin secreted by cancer‑associated fibroblasts promotes cancer progression and drug resistance in non‑small cell lung cancer
86. Successful Living-donor Lobar Lung Transplantation With BK Virus-related Hemorrhagic Cystitis Throughout the Perioperative Period
87. Five-Year Overall Survival Analysis of the JIPANG Study: Pemetrexed or Vinorelbine Plus Cisplatin for Resected Stage II-IIIA Nonsquamous Non–Small-Cell Lung Cancer
88. The consecutive impact of COVID-19 on thoracic surgical procedures in Japan: an analysis of data from the National Clinical Database
89. NOTCH1 and CREBBP co‐mutations negatively affect the benefit of adjuvant therapy in completely resected EGFR‐mutated NSCLC: translational research of phase III IMPACT study
90. Impact of changes in skeletal muscle mass and quality during the waiting time on outcomes of lung transplantation
91. In vivo lung perfusion for prompt recovery from primary graft dysfunction after lung transplantation
92. Prognostic nutrition index affects the prognosis of patients undergoing trimodality therapy for locally advanced non-small cell lung cancer
93. Publisher Correction: Sarcopenia is associated with poor prognosis after chemoradiotherapy in patients with stage III non-small-cell lung cancer: a retrospective analysis
94. Sarcopenia is associated with poor prognosis after chemoradiotherapy in patients with stage III non-small-cell lung cancer: a retrospective analysis
95. Randomized phase II study of daily and alternate-day administration of S-1 for adjuvant chemotherapy in completely-resected stage I non-small cell lung cancer: results of the Setouchi Lung Cancer Group Study 1301
96. Lung stereotactic body radiation therapy for elderly patients aged ≥ 80 years with pathologically proven early-stage non-small cell lung cancer: a retrospective cohort study
97. Lung transplantation for idiopathic multicentric Castleman disease: potential efficacy and tolerability of a humanized anti-interleukin-6 receptor monoclonal antibody
98. Summary of the Japanese Respiratory Society statement for the treatment of lung cancer with comorbid interstitial pneumonia
99. Airway bacteria of the recipient but not the donor are relevant to post-lung transplant pneumonia
100. Pulmonary aspergillosis as a late complication after surgery for locally advanced non-small cell lung cancer treated with induction chemoradiotherapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.